Home/Filings/4/0001209191-21-062593
4//SEC Filing

Posner Christopher 4

Accession 0001209191-21-062593

CIK 0001346830other

Filed

Nov 2, 8:00 PM ET

Accepted

Nov 3, 8:15 AM ET

Size

10.1 KB

Accession

0001209191-21-062593

Insider Transaction Report

Form 4
Period: 2021-10-29
Posner Christopher
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Common Stock

    2021-10-29+5,94122,037 total
  • Award

    Common Stock

    2021-10-29+142,000164,037 total
  • Award

    Stock Option (Right to Buy)

    2021-10-29+566,000566,000 total
    Exercise: $16.83Exp: 2031-10-29Common Stock (566,000 underlying)
Footnotes (3)
  • [F1]Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person pursuant to an Employment Agreement, dated October 29, 2021, between the Reporting Person and the Issuer, whereby the Reporting Person is employed as a Senior Advisor to the Issuer effective October 29, 2021 and as President and Chief Executive Officer of the Issuer effective November 9, 2021 (the "Employment Agreement"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest in full on March 31, 2022, subject to the Reporting Person's continued service to the Issuer on such date.
  • [F2]Represents the number of shares underlying RSUs granted to the Reporting Person pursuant to the Employment Agreement. Each RSU represents the contingent right to receive one share of common stock of the Issuer. 25% of the RSUs will vest on October 29, 2022 and the remainder will vest over the following 12 equal quarterly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date.
  • [F3]25% of the shares will vest and become exercisable on October 29, 2022 and the remainder will vest over the following 12 equal quarterly installments, in each case, subject to the Reporting Person's continued service to the Issuer as of each such date. These options were granted to the Reporting Person pursuant to the Employment Agreement.

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1
  • filerCIK 0001748265

Filing Metadata

Form type
4
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 8:15 AM ET
Size
10.1 KB